Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Lorvotuzumab_mertansine> ?p ?o. }
Showing items 1 to 53 of
53
with 100 items per page.
- Lorvotuzumab_mertansine abstract "Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate of lorvotuzumab linked to mertansine intended for CD56 positive cancers (e.g. small-cell lung cancer, ovarian cancer).It has been granted Orphan drug status for Merkel cell carcinoma.It has reported encouraging Phase II results for small-cell lung cancer.".
- Lorvotuzumab_mertansine atcPrefix "none".
- Lorvotuzumab_mertansine casNumber "1008106-64-6".
- Lorvotuzumab_mertansine fdaUniiCode "0IVD6ASY0W".
- Lorvotuzumab_mertansine thumbnail Mertansine_mab_structure.svg?width=300.
- Lorvotuzumab_mertansine wikiPageID "31278688".
- Lorvotuzumab_mertansine wikiPageRevisionID "546127706".
- Lorvotuzumab_mertansine atcPrefix "none".
- Lorvotuzumab_mertansine casNumber "1008106".
- Lorvotuzumab_mertansine chemspiderid "NA".
- Lorvotuzumab_mertansine hasPhotoCollection Lorvotuzumab_mertansine.
- Lorvotuzumab_mertansine kegg "D09927".
- Lorvotuzumab_mertansine mabType "mab".
- Lorvotuzumab_mertansine source "zu".
- Lorvotuzumab_mertansine target Neural_cell_adhesion_molecule.
- Lorvotuzumab_mertansine type "mab".
- Lorvotuzumab_mertansine unii "0".
- Lorvotuzumab_mertansine verifiedfields "changed".
- Lorvotuzumab_mertansine verifiedrevid "458433927".
- Lorvotuzumab_mertansine subject Category:Experimental_cancer_drugs.
- Lorvotuzumab_mertansine subject Category:Monoclonal_antibodies_for_tumors.
- Lorvotuzumab_mertansine type Abstraction100002137.
- Lorvotuzumab_mertansine type Antibody115027189.
- Lorvotuzumab_mertansine type Chemical114806838.
- Lorvotuzumab_mertansine type Compound114818238.
- Lorvotuzumab_mertansine type Macromolecule114944888.
- Lorvotuzumab_mertansine type Material114580897.
- Lorvotuzumab_mertansine type Matter100020827.
- Lorvotuzumab_mertansine type Molecule114682133.
- Lorvotuzumab_mertansine type MonoclonalAntibodiesForTumors.
- Lorvotuzumab_mertansine type MonoclonalAntibody115029781.
- Lorvotuzumab_mertansine type OrganicCompound114727670.
- Lorvotuzumab_mertansine type Part113809207.
- Lorvotuzumab_mertansine type PhysicalEntity100001930.
- Lorvotuzumab_mertansine type Protein114728724.
- Lorvotuzumab_mertansine type Relation100031921.
- Lorvotuzumab_mertansine type Substance100019613.
- Lorvotuzumab_mertansine type Thing100002452.
- Lorvotuzumab_mertansine type Unit109465459.
- Lorvotuzumab_mertansine type Drug.
- Lorvotuzumab_mertansine type FunctionalSubstance.
- Lorvotuzumab_mertansine comment "Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate of lorvotuzumab linked to mertansine intended for CD56 positive cancers (e.g. small-cell lung cancer, ovarian cancer).It has been granted Orphan drug status for Merkel cell carcinoma.It has reported encouraging Phase II results for small-cell lung cancer.".
- Lorvotuzumab_mertansine label "Lorvotuzumab mertansine".
- Lorvotuzumab_mertansine label "Lorvotuzumab mertansine".
- Lorvotuzumab_mertansine label "لورفوتوزوماب مرتانسين".
- Lorvotuzumab_mertansine sameAs Lorvotuzumab_mertansine.
- Lorvotuzumab_mertansine sameAs m.0gjd3_l.
- Lorvotuzumab_mertansine sameAs Q527070.
- Lorvotuzumab_mertansine sameAs Q527070.
- Lorvotuzumab_mertansine sameAs Lorvotuzumab_mertansine.
- Lorvotuzumab_mertansine wasDerivedFrom Lorvotuzumab_mertansine?oldid=546127706.
- Lorvotuzumab_mertansine depiction Mertansine_mab_structure.svg.
- Lorvotuzumab_mertansine isPrimaryTopicOf Lorvotuzumab_mertansine.